Research Article
Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
Figure 8
Molecular characteristics of different risk groups. (a) GO enrichment in TCGA database. (b) KEGG pathways in TCGA database. (c) GSEA in the high-risk group. (d) GSEA in the low-risk group. (e) The mutated genes (top 10) in different risk groups.
(a) |
(b) |
(c) |
(d) |
(e) |